New Delhi, June 24 -- Shares of Reliance Industries are likely to attract investor interest in Thursday's trade, June 25, after the company said its wholly owned step-down subsidiary, Karkinos Healthcare, has completed HPV DNA screening for over one lakh women across India. The milestone marks an important step towards expanding access to high-quality cervical cancer screening and follow-up care.

Cervical cancer prevention is often limited not only by access to screening but also by loss to follow-up after a positive result. Karkinos Healthcare's model addresses both challenges through World Health Organization-recommended HPV DNA testing and a digitally enabled continuum of care that integrates awareness, screening, tracking, triage, na...